- Condition: Cataract
Interventions: Drug: 40 mg/mL Dexamethasone phosphate ophthalmic solution; Drug: 100 mM sodium citrate buffer solution
Sponsors: Eyegate Pharmaceuticals, Inc.; Eyegate Pharmaceuticals, Inc.
Not yet recruiting - verified May 2012 - Condition: Infertility
Interventions: Drug: clomiphene citrate with low dose gonadotropins; Drug: Gonal F or Follistim
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified April 2012 - Condition: Intraocular Lens Replacement
Interventions: Drug: OMS302; Drug: Placebo
Sponsors: Omeros Corporation; Omeros Corporation
Recruiting - verified May 2012 - Conditions: End Stage Renal Disease; Kidney Failure; Renal Failure; Hyperphosphatemia; ESRD
Intervention: Drug: ferric citrate
Sponsors: Keryx Biopharmaceuticals; Keryx Biopharmaceuticals
Not yet recruiting - verified March 2012 - Condition: HIV Prevention
Interventions: Drug: Rectal formulation (RF) of tenofovir 1% gel; Drug: Vaginal formulation (VF) of tenofovir 1% gel; Drug: Reduced glycerin vaginal formulation (RGVF) of tenofovir 1% gel; Radiation: Radiolabeling of study drugs and semen
Sponsors: University of Pittsburgh; Ian McGowan; National Institute of Allergy and Infectious Diseases (NIAID); CONRAD
Not yet recruiting - verified April 2012 - Condition: HIV Prevention
Interventions: Drug: Rectal formulation (RF) of tenofovir 1% gel; Drug: Vaginal formulations (original VF and reduced vaginal glycerin formulation RGVF) of tenofovir 1% gel; Drug: Universal HEC Placebo Gel Formulation
Sponsors: University of Pittsburgh; Ian McGowan; National Institute of Allergy and Infectious Diseases (NIAID); CONRAD
Not yet recruiting - verified April 2012 - Conditions: Secondary Hypogonadism; Low Testosterone
Interventions: Drug: enclomiphene citrate; Drug: Testosterone
Sponsors: Repros Therapeutics Inc.; Repros Therapeutics Inc.
Not yet recruiting - verified April 2012 - Conditions: Secondary Hypogonadism; Low Testosterone
Interventions: Drug: enclomiphene citrate; Drug: Placebo; Drug: Testosterone
Sponsors: Repros Therapeutics Inc.; Repros Therapeutics Inc.
Not yet recruiting - verified April 2012 - Conditions: Pharmacokinetic; Cmax; Tmax; Plasma AUC; Plasma [AUC(0-t)]; Plasma [AUC(0-672)]; (t1/2,λz)
Interventions: Drug: vandetanib; Drug: omeprazole; Drug: ranitidine
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified March 2012 - Condition: Malignant Neoplasm
Interventions: Drug: placebo administration; Drug: EMLA; Drug: propofol; Drug: fentanyl citrate
Sponsors: Comprehensive Cancer Center of Wake Forest University; Comprehensive Cancer Center of Wake Forest University; National Cancer Institute (NCI)
Recruiting - verified March 2012 - Condition: Anterior Uveitis
Interventions: Drug: 40 mg/mL Dexamethasone phosphate ophthalmic solution; Drug: Prednisolone Acetate (1%) Eyedrops; Drug: 100 mM sodium citrate buffer solution; Drug: Placebo Eyedrops
Sponsors: Eyegate Pharmaceuticals, Inc.; Eyegate Pharmaceuticals, Inc.
Recruiting - verified May 2012 - Conditions: Gestational Diabetes; Obesity
Interventions: Dietary Supplement: Magnesium citrate; Dietary Supplement: Placebo; Behavioral: Dietary modification
Sponsors: University of California, Los Angeles; University of California, Los Angeles
Recruiting - verified January 2012 - Condition: Infection; Dialysis Catheter
Interventions: Drug: NAC/Tigecycline/Heparin combination lock solution; Drug: Standard anticoagulant (Heparin or Citrate)
Sponsors: University of California, San Diego; University of California, San Diego
Not yet recruiting - verified November 2011 - Conditions: Anemia, Sickle Cell; Pain
Interventions: Drug: Fentanyl Citrate; Drug: Normal Saline
Sponsors: Montefiore Medical Center; hnin khine
Recruiting - verified April 2012 - Condition: HIV Prevention
Interventions: Drug: Tenofovir 1% vaginal gel; Drug: Depo-medroxyprogesterone acetate (DMPA); Drug: Oral contraceptive: LNG 150 mcg and EE 30 mcg
Sponsors: CONRAD; CONRAD
Recruiting - verified May 2012 - Condition: Arthritis
Intervention: Drug: sodium citrate and citric acid
Sponsors: Texas Tech University Health Sciences Center; Texas Tech University Health Sciences Center
Recruiting - verified August 2011 - Condition: Acute Kidney Injury
Intervention: Device: SCD
Sponsors: CytoPherx, Inc; CytoPherx, Inc
Recruiting - verified March 2012 - Conditions: Obesity; Vitamin D Deficiency
Intervention: Dietary Supplement: Vitamin D3 and Calcium
Sponsors: The Methodist Hospital System; The Methodist Hospital System; Texas Woman's University
Not yet recruiting - verified July 2011 - Condition: HIV Prevention
Intervention: Drug: Tenofovir 1% vaginal gel
Sponsors: CONRAD; CONRAD
Recruiting - verified March 2012 - Conditions: Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vitamin D Deficiency
Interventions: Dietary Supplement: Vitamin D and Calcium Citrate; Dietary Supplement: Placebo
Sponsors: Children's Hospital Los Angeles; Children's Hospital Los Angeles; The Leukemia and Lymphoma Society
Recruiting - verified September 2011 - Conditions: Ductal Breast Carcinoma in Situ; Lobular Breast Carcinoma in Situ; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer
Interventions: Procedure: neoadjuvant therapy; Procedure: therapeutic conventional surgery; Other: laboratory biomarker analysis; Other: enzyme-linked immunosorbent assay; Genetic: gene expression analysis; Drug: systemic chemotherapy; Drug: tamoxifen citrate; Drug: aromatase inhibition therapy
Sponsors: Virginia Commonwealth University; Virginia Commonwealth University; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: Breast Cancer
Interventions: Drug: anastrozole; Drug: exemestane; Drug: letrozole; Drug: systemic chemotherapy; Drug: tamoxifen citrate
Sponsors: National Cancer Institute (NCI); Southwest Oncology Group; National Cancer Institute (NCI)
Recruiting - verified February 2012 - Condition: Rotavirus
Interventions: Biological: RotaTeq®; Biological: Rotarix®
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified March 2012 - Condition: Breast Cancer
Interventions: Drug: anastrozole; Drug: entinostat; Drug: tamoxifen citrate; Genetic: reverse transcriptase-polymerase chain reaction; Other: immunohistochemistry staining method; Other: laboratory biomarker analysis; Other: pharmacological study; Procedure: therapeutic conventional surgery
Sponsors: National Cancer Institute (NCI); University of Chicago; National Cancer Institute (NCI)
Recruiting - verified January 2011 - Conditions: HIV Infection; Bone Loss; Osteopenia; Osteoporosis
Intervention: Drug: Zoledronic acid
Sponsors: Emory University; Emory University
Recruiting - verified March 2012 - Conditions: Burns; Hemofiltration; Kidney Failure, Acute; Shock, Septic
Interventions: Device: An FDA approved continuous renal replacement device; Other: Control Group
Sponsors: United States Army Institute of Surgical Research; United States Army Institute of Surgical Research; American Burn Association; The University of Texas Health Science Center, Houston; Tampa General Hospital; Washington Hospital Center; Loyola University; University of Texas Southwestern Medical Center; Maricopa Integrated Health System; University of Tennessee Health Science Center
Recruiting - verified April 2012 - Conditions: AML; ALL; CML in Blast Crisis; High-Risk MDS; Multiple Myeloma
Intervention: Drug: TG02 citrate
Sponsors: Tragara Pharmaceuticals, Inc.; Tragara Pharmaceuticals, Inc.
Recruiting - verified December 2011 - Condition: Breast Cancer
Interventions: Drug: Tamoxifen Citrate; Drug: Placebo
Sponsors: City of Hope Medical Center; City of Hope Medical Center; National Cancer Institute (NCI); St. Jude Children's Research Hospital; University Health Network, Toronto; Emory University; University of Michigan
Recruiting - verified February 2012 - Conditions: Hypogonadotropic Hypogonadism; Type 2 Diabetes
Interventions: Drug: testosterone; Drug: clomiphene; Drug: placebo; Drug: placebo
Sponsors: State University of New York at Buffalo; State University of New York at Buffalo; American Diabetes Association
Recruiting - verified July 2011 - Condition: Breast Cancer
Interventions: Drug: tamoxifen citrate; Other: laboratory biomarker analysis
Sponsors: National Cancer Institute (NCI); Eastern Cooperative Oncology Group; National Cancer Institute (NCI)
Recruiting - verified February 2012 - Conditions: Pregnancy; Unexplained Infertility
Interventions: Drug: Letrozole (aromatase inhibitor); Drug: Clomiphene Citrate; Drug: Follicle Stimulating Hormone (gonadotropin)
Sponsors: Yale University; Yale University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Penn State University; University of Colorado, Denver; University of Michigan; University of Pennsylvania; University of Texas; University of Vermont; Wayne State University
Recruiting - verified January 2012 - Conditions: Penile Cancer; Erectile Dysfunction; Radical Prostatectomy
Interventions: Drug: Placebo QHS and sildenafil and questionnaires; Drug: Sildenafil and questionnaire; Drug: Trimix combination (Papavarine 30mg/mL Phentholamine 1mg/mL Prostaglandin E1 10 mcg/mmL) and questionnaires
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center; Pfizer
Recruiting - verified January 2012 - Conditions: Low Testosterone Levels; Erectile Dysfunction
Interventions: Drug: Testim® + Viagra®; Drug: Placebo Testim® + Viagra®
Sponsors: Baylor College of Medicine; Mohit Khera
Recruiting - verified December 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: Etanercept; Drug: Adalimumab
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2012 - Conditions: Apnea of Prematurity; Intraventricular Hemorrhage; White Matter Injury
Intervention: Drug: Caffeine citrate
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified August 2011 - Conditions: Breast Cancer; Depression; Hot Flashes; Psychosocial Effects of Cancer and Its Treatment
Interventions: Drug: citalopram hydrobromide; Drug: escitalopram oxalate; Drug: gabapentin; Drug: sertraline hydrochloride; Drug: tamoxifen citrate; Drug: venlafaxine; Genetic: molecular genetic technique; Other: high performance liquid chromatography; Other: laboratory biomarker analysis; Other: pharmacological study; Procedure: adjuvant therapy
Sponsors: Mayo Clinic; Mayo Clinic; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: Autistic Disorder
Interventions: Dietary Supplement: B12; Dietary Supplement: Placebo; Dietary Supplement: folate; Dietary Supplement: B complex; Dietary Supplement: vitamin C; Dietary Supplement: cod liver oil; Dietary Supplement: Mineral complex; Dietary Supplement: carnitine
Sponsors: Arkansas Children's Hospital Research Institute; Arkansas Children's Hospital Research Institute
Recruiting - verified January 2012 - Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Bosentan; Drug: Sildenafil Citrate
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Breast Cancer
Interventions: Drug: anastrozole; Drug: chemotherapy; Drug: exemestane; Drug: letrozole; Drug: tamoxifen citrate
Sponsors: National Cancer Institute (NCI); Eastern Cooperative Oncology Group; National Cancer Institute (NCI); Southwest Oncology Group; Cancer and Leukemia Group B; American College of Surgeons; North Central Cancer Treatment Group; NCIC Clinical Trials Group; National Surgical Adjuvant Breast and Bowel Project (NSABP)
Recruiting - verified July 2011 - Conditions: Cervical Cancer; Endometrial Cancer; Fallopian Tube Cancer; Ovarian Cancer; Pain; Perioperative/Postoperative Complications; Sarcoma
Interventions: Drug: fentanyl citrate; Drug: hydromorphone hydrochloride; Drug: ropivacaine hydrochloride
Sponsors: National Cancer Institute (NCI); University of California, San Francisco; National Cancer Institute (NCI)
Recruiting - verified September 2007 - Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Sildenafil citrate; Drug: Sildenafil citrate; Drug: Sildenafil citrate
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Conditions: Autonomic Failure; Orthostatic Hypotension
Interventions: Drug: Atomoxetine; Drug: Acarbose; Drug: Pyridostigmine Bromide; Drug: Yohimbine; Drug: Midodrine HCl; Drug: placebo; Drug: Modafinil; Drug: Octreotide; Other: water intake; Drug: Diphenhydramine Hydrochloride; Drug: Ranitidine HCL; Drug: Tranylcypromine; Drug: Ergotamine/ Caffeine; Drug: Celecoxib; Drug: Pseudoephedrine; Drug: Methylphenidate; Drug: Indomethacin; Drug: Ibuprofen; Drug: Oxymetazoline 0.05% nasal solution; Dietary Supplement: Bovril; Drug: Acetazolamide; Drug: Rivastigmine tartrate; Drug: Carbidopa/levodopa; Device: abdominal binder; Device: abdominal binder (sham)
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified May 2012 - Condition: Glioma
Interventions: Drug: Tamoxifen citrate; Drug: Bortezomib
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified July 2011


